EUCTR2015-000322-11-AT进行中（未招募）不适用
Assessment of the Duration of Glucagon’s Waning Effect on the Hepatic Glucose Production in Type 1 Diabetes Patients
Medizinische Universität Graz; Universitätsklinik für Innere Medizin; Abteilung für Endokrinologie und Stoffwechsel0 个研究点开始时间: 2015年2月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Type 1 diabetes treated with multiple daily insulin injections or continuous subcutaneous insulin infusion for 12 months
- •Male or female aged 18-65 years (both inclusive)
- •HbA1c < 10%
- •Informed consent obtained after being advised of the nature of the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 5
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Pregnancy, breast-feeding, intention of becoming pregnant, or not using adequate contraception
- •Any disease or condition which would interfere with the subject's safety
- •Skin pathology or condition prohibiting needle insertion/glucagon administration as judged by the investigator
- •Severe acute diseases
- •Current participation in another clinical study
- •Uncontrolled hypertension
- •Clinically overt diabetic complications
- •Mental incapacity, unwillingness, or language barriers precluding adequate understanding or cooperation
- •Taking any vasoactive substances or anticoagulatory medication
- •Use of a medication that significantly impacts glucose metabolism, i.e. oral or topical steroids, except in the case of a stable state with a minimum duration of at least 3 months preceeding the study as well as under the condition that the state remain stable for the duration of the study
- •Symptomatic coronary artery disease
- •Blood donation within 3 months preceeding the study
研究者
相似试验
进行中（未招募）
不适用
Testing Whether Glucagon Solutions Affect the Glucose Levels in the Fat Tissue of Diabetic Patients.EUCTR2014-002341-22-ATMedizinische Universität Graz; Universitätsklinik für InnereMedizin; Abteilung für Endokrinologie und Stoffwechsel
已完成
不适用
Evaluation of change in blood glucagon levels in response to orally glucose loading and food intakeDiabetes mellitusJPRN-UMIN000027852Gunma University70
招募中
不适用
Study of glucagon response and its association with glycemic control and variability after administration of ipragliflozin as an adjunctive to insulin treatment in patients with type 1 diabetes (Suglat-AID): a single-arm, multicenter, open-label,prospective exploratory trialtype 1 diabetesJPRN-UMIN000039635agasaki University Hospital24
已完成
不适用
Effect of the glucagon suppression ability in the sulfonylurea agents and other oral hypoglycemic agents.Type 2 diabetesJPRN-UMIN000007378Divison of Diabetes and Metabolism,Itabashi Hospital, Nihon University School of Medicine200
已完成
不适用
Comparison of fluctuation of glucagon after oral glucose, protein or lipid intake in healthy Japanese adult.healthy Japanese adultJPRN-UMIN000026502Department of Endocrinology, Diabetes and Metabolism, Kitasato University, School of Medicine10